Citius Oncology, Inc. (CTOR)
0.791
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 11:30
Citius Oncology Price to Book Value : 2.071 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 03, 2026 | 2.075 |
| September 02, 2026 | 2.037 |
| September 01, 2026 | 1.964 |
| August 31, 2026 | 1.999 |
| August 28, 2026 | 2.031 |
| August 27, 2026 | 2.070 |
| August 26, 2026 | 2.061 |
| August 25, 2026 | 2.122 |
| August 24, 2026 | 1.964 |
| August 21, 2026 | 1.948 |
| August 20, 2026 | 1.988 |
| August 19, 2026 | 1.971 |
| August 18, 2026 | 1.841 |
| August 17, 2026 | 1.938 |
| August 14, 2026 | 2.383 |
| August 13, 2026 | 2.165 |
| August 12, 2026 | 2.125 |
| August 11, 2026 | 1.912 |
| August 10, 2026 | 1.931 |
| August 07, 2026 | 1.972 |
| August 06, 2026 | 1.990 |
| August 05, 2026 | 2.056 |
| August 04, 2026 | 1.728 |
| August 03, 2026 | 1.638 |
| July 31, 2026 | 1.551 |
| Date | Value |
|---|---|
| July 30, 2026 | 1.503 |
| July 29, 2026 | 1.404 |
| July 28, 2026 | 1.418 |
| July 27, 2026 | 1.456 |
| July 24, 2026 | 1.472 |
| July 23, 2026 | 1.514 |
| July 22, 2026 | 1.501 |
| July 21, 2026 | 1.493 |
| July 20, 2026 | 1.493 |
| July 17, 2026 | 1.804 |
| July 16, 2026 | 1.786 |
| July 15, 2026 | 1.804 |
| July 14, 2026 | 1.702 |
| July 13, 2026 | 1.846 |
| July 10, 2026 | 1.810 |
| July 09, 2026 | 1.889 |
| July 08, 2026 | 1.911 |
| July 07, 2026 | 1.860 |
| July 06, 2026 | 1.856 |
| July 02, 2026 | 1.782 |
| July 01, 2026 | 1.844 |
| June 30, 2026 | 1.702 |
| June 29, 2026 | 1.822 |
| June 26, 2026 | 1.634 |
| June 25, 2026 | 1.74 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Citius Pharmaceuticals, Inc. | 0.2488 |
| ACADIA Pharmaceuticals, Inc. | 3.668 |
| Alnylam Pharmaceuticals, Inc. | 26.19 |
| Anika Therapeutics, Inc. | 2.043 |
| Savara, Inc. | 7.628 |
Price to Book Value Related Metrics
| PS Ratio | 10.47 |
| PEG Ratio | -0.0234 |
| Price | 0.791 |
| Earnings Yield | -59.89% |
| Market Cap | 83.66M |
| PEGY Ratio | -0.0234 |